Vitality Biopharma, Inc., a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, has announced results of recent drug formulation studies that documented substantial modifications to key physiochemical properties of cannabinoids through the production of cannaboside prodrug pharmaceuticals. Vitality Biopharma has demonstrated…